NASDAQ: ZVRA
Zevra Therapeutics Inc Earnings Dates, Reports, Calls

Zevra Therapeutics earnings were $78.0M for the trailing 12 months ending Sep 30, 2026, with 164.6% growth year over year. The latest ZVRA earnings report on Sep 30, 2026 announced Q3 2026 earnings of $19.2M, up 119.5% from last quarter. For the last reported fiscal year 2025 ending Dec 31, 2025, ZVRA reported annual earnings of $83.2M, with -178.9% growth.

ZVRA past earnings growth

How has ZVRA's earnings growth performed historically?

Company
164.58%
Industry
74.58%
Market
92.1%
ZVRA's earnings have grown faster... subscribe to Premium to read more.
Earnings Growth vs Industry Performance
ZVRA's earnings have grown faster... subscribe to Premium to read more.
Earnings Growth vs Market Performance
ZVRA's earnings growth is accelerating... subscribe to Premium to read more.
Accelerating Earnings Growth Performance

ZVRA earnings history

Current Revenue
$147.8M
Current Earnings
$78.0M
Current Profit Margin
52.8%

ZVRA Return on Equity

Current Company
38.2%
Current Industry
-19.8%
Current Market
35.9%
ZVRA's Return on Equity (38.2%)... subscribe to Premium to read more.
High Return on Equity Performance

ZVRA Return on Assets

Current Company
26.5%
Current Industry
-8.8%
ZVRA is generating higher Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

Be the first to know when ZVRA announces earnings.

ZVRA Return on Capital Employed

Current Company
34.4%
Current Industry
-4.2%
ZVRA has gotten more efficient... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

ZVRA vs Biotech Stocks

TickerEBITDAEarningsY/Y EarningsEPS
ZVRA$96.13M$78.02M+164.58%$1.27
WVE-$201.31M-$210.53MN/A-$1.06
SANA-$128.21M-$149.27MN/A-$0.53
AVBP-$169.07M-$169.07MN/A-$3.60
OBIO-$50.12M-$58.36MN/A-$0.75

Zevra Therapeutics Earnings Reports & History FAQ

What were Zevra Therapeutics's earnings last quarter?

On ZVRA's earnings call on Nov 3, 2026, Zevra Therapeutics (NASDAQ: ZVRA) reported Q3 2026 earnings per share (EPS) of $0.31, up 3,200% year over year. Total ZVRA earnings for the quarter were $19.21 million. In the same quarter last year, Zevra Therapeutics's earnings per share (EPS) was -$0.01.

If you're new to stock investing, here's how to buy Zevra Therapeutics stock.

Is Zevra Therapeutics profitable or losing money?

As of the last Zevra Therapeutics earnings report, Zevra Therapeutics is currently profitable. Zevra Therapeutics's net profit (also called net income) for the twelve months ending Sep 30, 2026 was $78.02 million, a 120.85% increase year over year.

What was ZVRA's earnings growth in the past year?

As of Zevra Therapeutics's earnings date in Nov 3, 2026, Zevra Therapeutics's earnings has grown 164.58% year over year. This is 90 percentage points higher than the US Biotechnology industry earnings growth rate of 74.58%. ZVRA earnings in the past year totalled $78.02 million.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.